(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1320105 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TM4SF1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1320106 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TM4SF1 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:1320106 6480464 vinylidene chloride results in decreased expression of TM4SF1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1320106 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TM4SF1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1320106 6480464 1, 2-Dimethylhydrazine results in decreased expression of TM4SF1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1320106 6480464 Ethinyl Estradiol affects the expression of TM4SF1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1320106 6480464 Ethinyl Estradiol results in increased expression of TM4SF1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1320105 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of TM4SF1 mRNA more ... CTD PMID:24758408 more ... 17beta-estradiol decreases expression ISO RGD:1320105 6480464 Estradiol results in decreased expression of TM4SF1 mRNA CTD PMID:19167446 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1320105 6480464 Dihydrotestosterone results in increased expression of TM4SF1 mRNA CTD PMID:29581250 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:1320105 6480464 2 more ... CTD PMID:36804509 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1320106 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1320105 6480464 Tetrachlorodibenzodioxin results in decreased expression of TM4SF1 mRNA CTD PMID:21802500 , PMID:30096437 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TM4SF1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TM4SF1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TM4SF1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320105 6480464 Tetrachlorodibenzodioxin results in increased expression of TM4SF1 mRNA CTD PMID:12377990 , PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320105 6480464 Tetrachlorodibenzodioxin affects the expression of TM4SF1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320106 6480464 Tetrachlorodibenzodioxin affects the expression of TM4SF1 mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression ISO RGD:1320106 6480464 2, 4-diaminotoluene results in increased expression of TM4SF1 mRNA CTD PMID:20713471 2-butoxyethanol increases expression ISO RGD:1320106 6480464 n-butoxyethanol results in increased expression of TM4SF1 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:1320105 6480464 Lactic Acid results in increased expression of TM4SF1 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of TM4SF1 mRNA CTD PMID:28522335 3-methylcholanthrene increases expression ISO RGD:1320106 6480464 Methylcholanthrene results in increased expression of TM4SF1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO RGD:1320106 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of TM4SF1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1320106 6480464 Fenretinide results in increased expression of TM4SF1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of TM4SF1 mRNA CTD PMID:24780913 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of TM4SF1 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:1320105 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of TM4SF1 mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1320105 6480464 Aflatoxin B1 affects the expression of TM4SF1 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1320105 6480464 Aflatoxin B1 results in increased expression of TM4SF1 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1320106 6480464 Aflatoxin B1 results in decreased expression of TM4SF1 mRNA CTD PMID:19770486 antirheumatic drug increases expression ISO RGD:1320105 6480464 Antirheumatic Agents results in increased expression of TM4SF1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1320105 6480464 aristolochic acid I results in increased expression of TM4SF1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1320105 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of TM4SF1 mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO RGD:1320105 6480464 arsenite results in decreased expression of TM4SF1 mRNA CTD PMID:31646340 arsenous acid increases expression ISO RGD:1320105 6480464 Arsenic Trioxide results in increased expression of TM4SF1 mRNA CTD PMID:22521957 arsenous acid decreases expression ISO RGD:1320105 6480464 Arsenic Trioxide results in decreased expression of TM4SF1 mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO RGD:1320106 6480464 Benzo(a)pyrene results in decreased expression of TM4SF1 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1320105 6480464 Benzo(a)pyrene results in increased methylation of TM4SF1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1320105 6480464 Benzo(a)pyrene results in increased expression of TM4SF1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene increases expression ISO RGD:1320106 6480464 Benzo(a)pyrene results in increased expression of TM4SF1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1320105 6480464 Benzo(a)pyrene results in decreased expression of TM4SF1 mRNA CTD PMID:21802500 beta-naphthoflavone decreases expression ISO RGD:1320105 6480464 beta-Naphthoflavone results in decreased expression of TM4SF1 mRNA CTD PMID:32858204 bexarotene increases expression ISO RGD:1320105 6480464 bexarotene results in increased expression of TM4SF1 mRNA CTD PMID:17178900 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1320105 6480464 Diethylhexyl Phthalate results in increased expression of TM4SF1 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TM4SF1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1320106 6480464 bisphenol A results in increased expression of TM4SF1 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A decreases expression ISO RGD:1320105 6480464 bisphenol A results in decreased expression of TM4SF1 mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:1320105 6480464 bisphenol A affects the expression of TM4SF1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1320105 6480464 bisphenol A results in increased expression of TM4SF1 mRNA CTD PMID:27685785 bisphenol F increases expression ISO RGD:1320106 6480464 bisphenol F results in increased expression of TM4SF1 mRNA CTD PMID:30951980 cadmium atom decreases expression ISO RGD:1320105 6480464 Cadmium results in decreased expression of TM4SF1 mRNA CTD PMID:16439709 more ... cadmium atom multiple interactions ISO RGD:1320105 6480464 Fulvestrant inhibits the reaction [Cadmium results in decreased expression of TM4SF1 mRNA] CTD PMID:31646340 cadmium atom increases expression ISO RGD:1320105 6480464 Cadmium results in increased expression of TM4SF1 mRNA CTD PMID:23369406 cadmium dichloride multiple interactions ISO RGD:1320105 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA CTD PMID:12634122 calcitriol multiple interactions ISO RGD:1320105 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TM4SF1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1320105 6480464 Calcitriol results in increased expression of TM4SF1 mRNA CTD PMID:26485663 calcitriol decreases expression ISO RGD:1320105 6480464 Calcitriol results in decreased expression of TM4SF1 mRNA CTD PMID:16002434 , PMID:21592394 carbamazepine affects expression ISO RGD:1320105 6480464 Carbamazepine affects the expression of TM4SF1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1320106 6480464 Nanotubes, Carbon analog results in increased expression of TM4SF1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1320106 6480464 Nanotubes, Carbon results in decreased expression of TM4SF1 mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:1320105 6480464 CGP 52608 promotes the reaction [RORA protein binds to TM4SF1 gene] CTD PMID:28238834 chloropicrin increases expression ISO RGD:1320105 6480464 chloropicrin results in increased expression of TM4SF1 mRNA CTD PMID:26352163 chromium(6+) affects expression ISO RGD:1320106 6480464 chromium hexavalent ion affects the expression of TM4SF1 mRNA CTD PMID:28472532 coumestrol multiple interactions ISO RGD:1320105 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1320105 6480464 Asbestos, Crocidolite results in increased expression of TM4SF1 mRNA CTD PMID:25351596 crocidolite asbestos decreases expression ISO RGD:1320105 6480464 Asbestos, Crocidolite results in decreased expression of TM4SF1 mRNA CTD PMID:29523930 cyclophosphamide increases expression ISO RGD:1320105 6480464 Cyclophosphamide results in increased expression of TM4SF1 mRNA CTD PMID:17403535 cyclosporin A decreases expression ISO RGD:1320106 6480464 Cyclosporine results in decreased expression of TM4SF1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1320105 6480464 Cyclosporine results in decreased expression of TM4SF1 mRNA CTD PMID:19159671 more ... diarsenic trioxide decreases expression ISO RGD:1320105 6480464 Arsenic Trioxide results in decreased expression of TM4SF1 mRNA CTD PMID:20458559 diarsenic trioxide increases expression ISO RGD:1320105 6480464 Arsenic Trioxide results in increased expression of TM4SF1 mRNA CTD PMID:22521957 dibutyl phthalate increases expression ISO RGD:1320106 6480464 Dibutyl Phthalate results in increased expression of TM4SF1 mRNA CTD PMID:21266533 dichromium trioxide multiple interactions ISO RGD:1320105 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA CTD PMID:12634122 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of TM4SF1 mRNA CTD PMID:21161181 dioxygen increases expression ISO RGD:1320105 6480464 Oxygen deficiency results in increased expression of TM4SF1 mRNA CTD PMID:24236059 dioxygen multiple interactions ISO RGD:1320106 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of TM4SF1 mRNA CTD PMID:19640911 dorsomorphin multiple interactions ISO RGD:1320105 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of TM4SF1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1320105 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA CTD PMID:19167446 epoxiconazole decreases expression ISO RGD:1320106 6480464 epoxiconazole results in decreased expression of TM4SF1 mRNA CTD PMID:35436446 folic acid affects expression ISO RGD:1320105 6480464 Folic Acid affects the expression of TM4SF1 mRNA CTD PMID:17320366 folic acid decreases expression ISO RGD:1320105 6480464 Folic Acid results in decreased expression of TM4SF1 mRNA CTD PMID:21867686 folic acid decreases expression ISO RGD:1320106 6480464 Folic Acid results in decreased expression of TM4SF1 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1320106 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TM4SF1 mRNA CTD PMID:22206623 fulvestrant multiple interactions ISO RGD:1320105 6480464 Fulvestrant inhibits the reaction [arsenite results in decreased expression of TM4SF1 mRNA] more ... CTD PMID:31646340 fulvestrant increases methylation ISO RGD:1320105 6480464 Fulvestrant results in increased methylation of TM4SF1 gene CTD PMID:31601247 fulvestrant increases expression ISO RGD:1320105 6480464 Fulvestrant results in increased expression of TM4SF1 mRNA CTD PMID:31646340 furan increases expression EXP 6480464 furan results in increased expression of TM4SF1 mRNA CTD PMID:27387713 gold atom increases expression ISO RGD:1320105 6480464 Gold results in increased expression of TM4SF1 mRNA CTD PMID:29705079 gold(0) increases expression ISO RGD:1320105 6480464 Gold results in increased expression of TM4SF1 mRNA CTD PMID:29705079 isoflavones affects expression ISO RGD:1320105 6480464 Isoflavones affects the expression of TM4SF1 mRNA CTD PMID:16365062 isoflavones decreases expression ISO RGD:1320105 6480464 Isoflavones results in decreased expression of TM4SF1 mRNA CTD PMID:17374662 ivermectin increases expression ISO RGD:1320105 6480464 Ivermectin results in increased expression of TM4SF1 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:1320105 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of TM4SF1 mRNA CTD PMID:17639512 lead diacetate multiple interactions ISO RGD:1320105 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA CTD PMID:12634122 leflunomide increases expression ISO RGD:1320105 6480464 leflunomide results in increased expression of TM4SF1 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1320105 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of TM4SF1 mRNA CTD PMID:35877022 lithium chloride increases expression ISO RGD:1320105 6480464 Lithium Chloride results in increased expression of TM4SF1 mRNA CTD PMID:15711924 methylisothiazolinone increases expression ISO RGD:1320105 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of TM4SF1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1320105 6480464 methylmercuric chloride results in increased expression of TM4SF1 mRNA CTD PMID:28001369 methylparaben decreases expression ISO RGD:1320105 6480464 methylparaben results in decreased expression of TM4SF1 mRNA CTD PMID:31745603 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of TM4SF1 mRNA CTD PMID:29162477 nickel sulfate decreases expression ISO RGD:1320105 6480464 nickel sulfate results in decreased expression of TM4SF1 mRNA CTD PMID:22714537 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of TM4SF1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TM4SF1 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of TM4SF1 mRNA CTD PMID:31397875 paracetamol affects expression ISO RGD:1320106 6480464 Acetaminophen affects the expression of TM4SF1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TM4SF1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1320105 6480464 Acetaminophen results in decreased expression of TM4SF1 mRNA CTD PMID:22230336 , PMID:29067470 paracetamol increases expression ISO RGD:1320106 6480464 Acetaminophen results in increased expression of TM4SF1 mRNA CTD PMID:11264010 paraquat increases expression EXP 6480464 Paraquat results in increased expression of TM4SF1 mRNA CTD PMID:32680482 pentachlorophenol decreases expression ISO RGD:1320106 6480464 Pentachlorophenol results in decreased expression of TM4SF1 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1320106 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TM4SF1 mRNA CTD PMID:36331819 phenylmercury acetate increases expression ISO RGD:1320105 6480464 Phenylmercuric Acetate results in increased expression of TM4SF1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1320105 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1320105 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TM4SF1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1320106 6480464 pirinixic acid results in increased expression of TM4SF1 mRNA CTD PMID:18301758 , PMID:23811191 pirinixic acid decreases expression ISO RGD:1320106 6480464 pirinixic acid results in decreased expression of TM4SF1 mRNA CTD PMID:18445702 piroxicam decreases expression ISO RGD:1320105 6480464 Piroxicam results in decreased expression of TM4SF1 mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1320105 6480464 potassium chromate(VI) results in decreased expression of TM4SF1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1320105 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TM4SF1 mRNA CTD PMID:22079256 quercetin multiple interactions ISO RGD:1320105 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of TM4SF1 mRNA CTD PMID:17639512 quercetin increases expression ISO RGD:1320105 6480464 Quercetin results in increased expression of TM4SF1 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1320105 6480464 Lactic Acid results in increased expression of TM4SF1 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1320105 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1320105 6480464 Silicon Dioxide analog results in increased expression of TM4SF1 mRNA, Silicon Dioxide results in increased expression of TM4SF1 mRNA CTD PMID:25351596 , PMID:25895662 silver atom decreases expression ISO RGD:1320106 6480464 Silver results in decreased expression of TM4SF1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1320106 6480464 Silver results in decreased expression of TM4SF1 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:1320105 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA CTD PMID:12634122 sodium arsenite increases expression ISO RGD:1320105 6480464 sodium arsenite results in increased expression of TM4SF1 mRNA CTD PMID:12377979 sodium arsenite decreases expression ISO RGD:1320105 6480464 sodium arsenite results in decreased expression of TM4SF1 mRNA CTD PMID:12634122 sodium dodecyl sulfate increases expression ISO RGD:1320105 6480464 Sodium Dodecyl Sulfate results in increased expression of TM4SF1 mRNA CTD PMID:31734321 Soman increases expression EXP 6480464 Soman results in increased expression of TM4SF1 mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1320105 6480464 Sunitinib results in decreased expression of TM4SF1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1320105 6480464 Tamoxifen affects the expression of TM4SF1 mRNA CTD PMID:14699072 tamoxifen affects expression ISO RGD:1320106 6480464 Tamoxifen affects the expression of TM4SF1 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:1320105 6480464 tert-Butylhydroperoxide results in increased expression of TM4SF1 mRNA CTD PMID:12766906 , PMID:15336504 testosterone decreases expression ISO RGD:1320105 6480464 Testosterone results in decreased expression of TM4SF1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1320105 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TM4SF1 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1320106 6480464 Carbon Tetrachloride affects the expression of TM4SF1 mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:1320106 6480464 Carbon Tetrachloride results in decreased expression of TM4SF1 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TM4SF1 mRNA CTD PMID:34492290 toluene increases expression EXP 6480464 Toluene results in increased expression of TM4SF1 mRNA CTD PMID:22967744 topotecan increases expression EXP 6480464 Topotecan results in increased expression of TM4SF1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TM4SF1 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of TM4SF1 mRNA CTD PMID:33387578 tunicamycin increases expression ISO RGD:1320105 6480464 Tunicamycin results in increased expression of TM4SF1 mRNA CTD PMID:33545341 valproic acid affects expression ISO RGD:1320106 6480464 Valproic Acid affects the expression of TM4SF1 mRNA CTD PMID:17292431 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of TM4SF1 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1320105 6480464 Valproic Acid results in increased expression of TM4SF1 mRNA CTD PMID:28001369 valproic acid decreases expression ISO RGD:1320105 6480464 Valproic Acid results in decreased expression of TM4SF1 mRNA CTD PMID:23179753 , PMID:29154799 valproic acid affects expression ISO RGD:1320105 6480464 Valproic Acid affects the expression of TM4SF1 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TM4SF1 mRNA CTD PMID:23034163